Product Description

🔹 Product Overview
Borviz 2.5 mg Injection is a prescription anti-cancer medicine used in the treatment of certain blood cancers.
Contains Bortezomib 2.5 mg, a proteasome inhibitor that helps slow the growth and spread of cancer cells.
Commonly prescribed for patients diagnosed with multiple myeloma and mantle cell lymphoma.

🔹 Key Uses
Treatment of multiple myeloma
Management of mantle cell lymphoma
Used as part of combination chemotherapy regimens
Helps control cancer progression and improve treatment outcomes

🔹 Composition
Active ingredient: Bortezomib 2.5 mg
Belongs to the Proteasome Inhibitor class
Used in hematology and oncology therapy

🔹 How It Works
Blocks proteasomes responsible for breaking down proteins within cancer cells
Causes accumulation of damaged proteins in cancer cells
Triggers cancer cell death and slows tumor growth

🔹 Key Benefits
Effective blood cancer treatment injection
Helps manage multiple myeloma and lymphoma
Supports targeted anti-cancer therapy
Can be used in combination with other chemotherapy medicines
Helps improve disease control and treatment response

🔹 Dosage and Administration
Administered only under the supervision of an oncology specialist
Given by intravenous or subcutaneous injection
Dosage depends on body size, medical condition, and treatment protocol
Regular monitoring is required during therapy

🔹 Possible Side Effects
Fatigue
Nausea and vomiting
Diarrhea or constipation
Low platelet count
Peripheral neuropathy (tingling or numbness in hands and feet)
Increased risk of infections

🔹 Precautions
Use only under strict medical supervision
Regular blood tests may be required
Inform your doctor about liver disease, infections, or nerve disorders
Avoid pregnancy during treatment
Follow all scheduled medical appointments and monitoring recommendations